Clinical Application of Al18F-NOTA-FAPI-04 PET/CT or PET/MRI Imaging in Malignant Tumor,Cardiovascular or Immune Disease
Recruiting now · Phase 1/Phase 2
Conditions studied: Hyperthyroidism, Autoimmune, Cardiovascular Abnormalities, Malignant Tumor
In brief
This prospective, single-center study investigates the biodistribution, dosimetry, safety, diagnostic performance of Al18F-NOTA-FAPI PET imaging in patients with malignant tumor,cardiovascular or immune disease. And evaluates the potential of Al18F-NOTA-FAPI PET imaging in Clinical treatment strategy guidance.
Key facts
- Study ID
- NCT07400224
- Run by
- Peking Union Medical College Hospital
- People needed
- 600
- Starts
- 2022-05-10
- Expected to finish
- 2028-12-31
- Last updated by the study team
- 2026-02-10
Who can join
Age: 18 and older, up to 88. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- a. Age 18 years old or above, gender not restricted. b. Have undergone a health check-up within the last 3 months (at least completed chest X-ray / chest CT and abdominal B-ultrasound and other examinations), and no major diseases were found.
You may not qualify if…
- As this study involves certain radiation exposure, patients who have had frequent radiation exposure due to clinical needs (those who have undergone a CT or PET/CT examination once within 3 months or 1 month respectively) are not included in the study.
Where it is running
- Peking Union Medical College Hospital — Beijing, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.